New York - Pfizer announced that Lipitor(R) (atorvastatin calcium) 80 mg showed unexpectedly potent reduction in myocardial ischemia (a condition defined by insufficient blood supply and oxygen to the heart) in patients with chronic stable angina (chest pain). These results were presented at the annual meeting of the American College of Cardiology.
At a recent local press conference at the Hilton Hotel, Johannesburg, the results of the landmark ONTARGET(R) trial were presented by Professor Pinky Sareli. This trial establishes telmisartan 80 mg as the only ARB clinically proven, to be as protective, but better tolerated than ramipril 10mg, in a broad high-risk cardiovascular population. From ONTARGET it may be concluded that telmisartan can prevent every 5th serious cardiovascular event. Prof Sareli further stated, categorically, that this is not an ARB class effect, but only applies to telmisartan.
To the Editor: Patient satisfaction as a component of healthcare outcomes assessment plays an important role in the roll-out and delivery of health services. The assessment of patient satisfaction with the quality of service is usually used to evaluate factors influencing the utilization of healthcare delivery systems.
To the Editor: This book presents the latest thinking on motivational interviewing (MI) by Steve Rollnick, Bill Miller and Chris Butler and is aimed at the wide variety of healthcare workers who engage with patients about lifestyle or behaviour change. In the South African context, with our quadruple burden of disease from HIV, chronic disorders, poverty-related conditions and trauma, it is easy to see the importance of conversations about sexual behaviour, adherence, obesity, as well as smoking, alcohol and other substance abuse.